Lotterer E, Fleig W E
Klinik und Poliklinik für Innere Medizin I, Martin-Luther-Universität Halle-Wittenberg.
Praxis (Bern 1994). 1997 Jan 21;86(4):104-8.
The hepatopulmonary syndrome (HPS) is a functional process and is characterized by the triad of liver cirrhosis, intrapulmonary vascular dilatations, and arterial hypoxemia in absence of detectable intrinsic disease of the lung and the heart. The pathophysiological fundament is the presence of a ventilation-perfusion (VA/Q) inequality based on marked vasodilatation of the pulmonary vessels at the precapillary level. Only in critically ill patients limitations of the diffusion of oxygen from the alveolar gas to the capillary blood and intrapulmonary arteriovenous communications will increasingly contribute to the hypoxemia. For diagnosis of the HPS the arterial blood gases (under condition of room air and 100% oxygen), the contrast echocardiography, the pulmonary angiography, and the multiple inert gas elimination technique will give important informations. Regarding recent studies liver transplantation is the treatment of choice in patients with severe HPS.
肝肺综合征(HPS)是一种功能性过程,其特征为肝硬化、肺内血管扩张和动脉血氧不足三联征,且不存在可检测到的肺和心脏内在疾病。病理生理学基础是基于肺血管在毛细血管前水平的明显血管扩张而出现的通气-灌注(VA/Q)失衡。只有在危重症患者中,氧气从肺泡气体向毛细血管血液扩散的限制以及肺内动静脉分流才会越来越多地导致低氧血症。对于HPS的诊断,动脉血气分析(在室内空气和100%氧气条件下)、对比超声心动图、肺血管造影和多惰性气体清除技术将提供重要信息。关于近期研究,肝移植是重度HPS患者的首选治疗方法。